Accolade Market Cap

Celltrion Pharm has a market cap or net worth of 2.31 trillion as of August 8, 2025. Its market cap has decreased by -40.29% in one year.

Market Cap

2.31T

Enterprise Value

n/a

Revenue

274.73B

Ranking

n/a

PE Ratio

89.07

Stock Price

$52,900.00

Market Cap Chart

Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 2.31T, an increase of 3,373.20%. That is a compound annual growth rate of 19.93%.

Market Cap History

Date	Market Cap	% Change
Aug 7, 2025	2,305.21B	-6.54%
Dec 30, 2024	2,466.43B	-35.41%
Dec 28, 2023	3,818.49B	44.48%
Dec 29, 2022	2,642.93B	-43.45%
Dec 30, 2021	4,673.68B	-46.31%
Dec 30, 2020	8,705.45B	511.51%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.38T
Celltrion	39.35T
ALTEOGEN	23.73T
Yuhan	8,599.10B
SK Biopharmaceuticals	7,948.79B
Peptron	7,292.07B
HLB Co., Ltd.	6,237.58B
PharmaResearch	5,859.76B

Market Cap Rankings